Expression of chemokine receptors CCR5 and CXCR4 on CD4 T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients
Journal of Acquired Immune Deficiency Syndromes, ISSN: 1525-4135, Vol: 39, Issue: 3, Page: 265-271
2005
- 23Citations
- 54Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations23
- Citation Indexes22
- CrossRef22
- 18
- Policy Citations1
- Policy Citation1
- Captures54
- Readers54
- 54
Article Description
The pathogenesis of persistently elevated plasma HIV viremia in patients coinfected with tuberculosis (TB) during anti-TB treatment in Africans remains unknown. We examined the expression of chemokine receptors CCR5 and CXCR4 on CD4 T cells and plasma chemokine levels of macrophage inflammatory protein (MIP)-1α, MIP-1β, regulated on activation normal T expressed and secreted (RANTES), and stromal cell-derived factor (SDF)-1α among TB patients with HIV coinfection during the first 2 months of anti-TB treatment. During treatment of TB, the plasma HIV-1 load and CD4 T-cell count remained unchanged. Levels of CCR5 and CXCR4 expression on CD4 T cells as well as plasma levels of chemokines remained persistently elevated during anti-TB treatment. Persistently elevated plasma HIV viremia also paralleled persistently elevated expressions of activated CCR5 or CXCR4 CD4 T cells. These results suggest that increased expression of CCR5 and CXCR4 on an activated CD4 T-cell population coupled with persistently elevated chemokines may provide a suitable condition for continuous replication of HIV associated with TB coinfection. This, in turn, may contribute, at least in part, to the observed persistently elevated plasma HIV viremia in coinfected patients despite anti-TB treatment. Copyright © 2005 by Lippincott Williams & Wilkins.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=21544438177&origin=inward; http://dx.doi.org/10.1097/01.qai.0000163027.47147.2e; http://www.ncbi.nlm.nih.gov/pubmed/15980685; https://journals.lww.com/00126334-200507010-00002; https://dx.doi.org/10.1097/01.qai.0000163027.47147.2e; https://journals.lww.com/jaids/Fulltext/2005/07010/Expression_of_Chemokine_Receptors_CCR5_and_CXCR4.2.aspx
Ovid Technologies (Wolters Kluwer Health)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know